Invention Grant
US09084807B2 Composition comprising ligustroflavone, rhoifolin and hyperin and its pharmaceutical application
有权
组合物，其包含连翘黄酮，rhoifolin和hyperin及其药物应用
- Patent Title: Composition comprising ligustroflavone, rhoifolin and hyperin and its pharmaceutical application
- Patent Title (中): 组合物，其包含连翘黄酮，rhoifolin和hyperin及其药物应用
-
Application No.: US13816105Application Date: 2011-08-04
-
Publication No.: US09084807B2Publication Date: 2015-07-21
- Inventor: Chunshan Tang , Ning Xie , Xiaoling Yang , Wuqing Lv , Zhiyong Li , Jingying Ye , Difa Liu , Fan Cheng
- Applicant: Chunshan Tang , Ning Xie , Xiaoling Yang , Wuqing Lv , Zhiyong Li , Jingying Ye , Difa Liu , Fan Cheng
- Applicant Address: CN Xinshanzhen, Anyuanxian, Ganzhou, Jiangxi CN Shahe Industrial Park, Ganzhou, Jiangxi
- Assignee: JIANXI SHANXIANG PHARMACEUTICAL CO. LTD.,JIANGXI QINGFENG PHARMACEUTICAL RESEARCH CO., LTD.
- Current Assignee: JIANXI SHANXIANG PHARMACEUTICAL CO. LTD.,JIANGXI QINGFENG PHARMACEUTICAL RESEARCH CO., LTD.
- Current Assignee Address: CN Xinshanzhen, Anyuanxian, Ganzhou, Jiangxi CN Shahe Industrial Park, Ganzhou, Jiangxi
- Agency: Global IP Services
- Agent Tianhua Gu
- Priority: CN201010253775 20100816
- International Application: PCT/CN2011/078016 WO 20110804
- International Announcement: WO2012/022223 WO 20120223
- Main IPC: A61K31/7048
- IPC: A61K31/7048 ; A61K9/00 ; A61K31/352 ; A61K45/06 ; A61K47/18 ; A61K36/185
Abstract:
Disclosed is a composition comprising ligustroflavone, rhoifolin and hyperin, which is prepared according to rational weight ratio: 40% to 80% ligustroflavone, 5% to 45% rhoifolin and 1% to 40% hyperin. The composition can be used as a neuraminidase inhibitor for preventing and treating influenza, and can be formulated into pharmaceutically acceptable dosage forms.
Public/Granted literature
- US20130131000A1 Composition Comprising Ligustroflavone, Rhoifolin and Hyperin and Its Pharmaceutical Application Public/Granted day:2013-05-23
Information query
